hypericin has been researched along with cyclosporine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chaloupka, R; Israël, N; Petit, PX; Sureau, F | 1 |
3 other study(ies) available for hypericin and cyclosporine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Over-expression of Bcl-2 does not protect cells from hypericin photo-induced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway.
Topics: 3T3 Cells; Animals; Anthracenes; Apoptosis; Bongkrekic Acid; Caspase 3; Caspases; Cell Line; Cell Membrane Permeability; Cyclosporine; Dose-Response Relationship, Radiation; Enzyme Activation; Fibroblasts; Flow Cytometry; Fluoresceins; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; Membrane Potentials; Mice; Microscopy, Confocal; Mitochondria; Perylene; Phosphatidylserines; Photosensitivity Disorders; Proto-Oncogene Proteins c-bcl-2; Time Factors | 1999 |